Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Published Online: 2016-07-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Christine Horak•Craig L Slingluff•Donald P Lawrence•Elizabeth I Buchbinder•Elmer Berghorn•F Stephen Hodi•Geoff Gibney•George Kong•Jeffrey A Sosman•Jeffrey S Weber•Joel Jiang•Leslie Fecher•Lynn M Schuchter•Mary Ruisi•Ryan J Sullivan•Suresh Nair•Theodore F Logan
